文献速递临床试验与 GCP

冥想对2型糖尿病患者生理与代谢指标的影响「MindDM」:随机对照试验研究方案

Effects of meditation on physiological and metabolic parameters in patients with type 2 diabetes mellitus "MindDM": study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2022-09-30

本研究为开放标签随机对照试验,计划在斯里兰卡科伦坡大学医学院招募172例2型糖尿病患者,按1:1区组随机分为冥想组与等待组。冥想组在常规治疗基础上接受为期12周、每周一次的正念冥想课程。主要结局为HbA1c,次要结局包括空腹血糖、果糖胺、胰岛素抵抗、24小时尿皮质醇、体重指数、心脏自主神经反射测试及口盲转运时间。

要点

  • 冥想组在常规治疗基础上接受12周正念冥想课程,等待组仅接受常规治疗。
  • 主要结局为HbA1c,次要结局包括空腹血糖、果糖胺、胰岛素抵抗及24小时尿皮质醇等。
  • 所有结局指标在干预开始前和3个月后于两组中分别测量。

核心结论

  • 本研究旨在识别正念冥想对血糖控制的影响及其可能通过神经体液和自主神经功能介导的机制。

研究设计与样本

  • 开放标签随机对照临床试验,在科伦坡大学医学院开展。
  • 计划招募172例在教授单元内科门诊就诊的2型糖尿病患者,依据纳入排除标准招募。
  • 从未冥想或极少冥想(少于每三个月一次)的患者采用区组随机化按1:1分配至冥想组和等待组。

主要发现

  • 原文为研究方案,未报告结果数据。

关键数值与推荐

  • 主要结局指标为HbA1c。
  • 次要结局指标包括空腹血糖、果糖胺、胰岛素抵抗(用空腹血清胰岛素计算)、24小时尿皮质醇、体重指数、心脏自主神经反射测试(Ewing试验组合)及使用氢呼气分析测定的口盲转运时间。
  • 所有指标在干预开始前和3个月后于两组中分别进行测量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sri Lanka is faced with the challenge of managing a large population with diabetes mellitus by 2030. Psychological stress plays a major role in disease outcome by exerting physiological, psychological and social effects on individuals with chronic disorders. Meditation-based interventions have positive effects on the management of stress and diabetes, which are mediated via modulation of neuro-humoral mechanisms and autonomic functions, among others. Mechanisms of bio-physiological effects of meditation are considered to be through reduction of stress hormones, improvement of insulin resistance and improvement of autonomic dysfunction. METHODS: This study will be conducted as an open-label, randomized controlled clinical trial in the Faculty of Medicine, University of Colombo. The aim is to investigate the effects of meditation on glycaemic control and possible mechanisms of how meditation affects glycaemic control in patients with type 2 diabetes. The study was approved by the Ethics Review Committee of the Faculty of Medicine, University of Colombo (ERC/2019/094). Patients who are attending the professorial unit medical clinic with type 2 diabetes (172 in total) will be recruited based on inclusion-exclusion criteria. Patients who have never meditated or rarely meditated (less than once every three months) will be randomized using block randomization to meditation and waitlisted arms (1:1 allocation ratio). The meditation arm will undergo a mindfulness meditation program (selected after studying several meditation methods) conducted by a qualified instructor weekly for a period of 12 weeks in addition to usual care, while the waitlisted arm will only receive usual care. Daily meditation practices will be recorded in a diary. The primary outcome measure is HbA1c. Secondary outcome measures are fasting blood sugar, fructosamine, insulin resistance (calculated using fasting serum insulin), 24-h urinary cortisol, body mass index, cardiac autonomic reflex testing (Ewing's battery of tests) and orocecal transit time using hydrogen breath analysis. All these will be done prior to commencement of the intervention and after 3 months in both arms. Data will be analysed using SPSS V-23. DISCUSSION: This study aims to identify the effect of mindfulness meditation on glycaemic control and the possible mechanisms (neuro humoral and autonomic functions) by which beneficial effects are mediated. TRIAL REGISTRATION: Registered under Sri Lanka Clinical Trial Registry: SLCTR/2021/015 The Universal Trial Number (UTN) U1111-1266-8640.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Dalpatadu KPC, Galappatthy P, Katulanda P, et al. Effects of meditation on physiological and metabolic parameters in patients with type 2 diabetes mellitus "MindDM": study protocol for a randomized controlled trial. Trials. 2022. PMID: 36176007. doi:10.1186/s13063-022-06771-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。